Chitosan-decorated selenium nanoparticles as protein carriers to improve the in vivo half-life of the peptide therapeutic BAY 55-9837 for type 2 diabetes mellitus. [electronic resource]
- International journal of nanomedicine 2014
- 4819-28 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1178-2013
10.2147/IJN.S67871 doi
Animals Chitosan--chemistry Diabetes Mellitus, Type 2 Drug Carriers--chemistry Drug Stability Half-Life Mice Nanoparticles--chemistry Particle Size Peptide Fragments--chemistry Selenium--chemistry Vasoactive Intestinal Peptide--chemistry